Introduction {#sec1_1}
============

Compresses containing a nonsteroidal antiinflammatory drug (NSAID) are frequently used in Japan. However, the style of the application may induce both allergic and photoallergic contact dermatitis from the NSAIDs and their ingredients \[[@B1],[@B2],[@B3]\]. We describe a case of allergic contact dermatitis with diffuse erythematous reaction caused by allergic sensitivity to a component, diisopropanolamine, of a compress used by the patient.

Case Report {#sec1_2}
===========

An 87-year-old Japanese man with dementia presented with a pruritic eruption following the use of compresses for lumbago. The patient had used the same compresses for three weeks. During the last ten days of use, pruritic eruptions appeared on the bilateral lower back and upper buttock where the compresses were being applied. Then, diffuse erythema developed on the trunk and extremities. Physical examination revealed rectangular-shaped, pruritic exudative erythematous macular lesions on the bilateral lower back and upper buttock and diffuse erythema on the chest, abdomen, back and extremities (fig. [1](#F1){ref-type="fig"}). The dermatitis was treated with topical steroids.

A patch test (International Contact Dermatitis Research Group criteria; Finn Chambers® on Scanpor® tape, Epitest Ltd., Tuusula, Finland) was performed with the compress' ingredients and the Japanese baseline series. The manufacturer provided the ingredients. The positive reactions at both 2 and 4 days after application were to diisopropanolamine 1% pet., fragrance mix 8% pet. (brial allergen GmbH, Greven, Germany), and mercuric chloride 0.05% aq. (Torii Pharmaceutical Co., Ltd., Tokyo, Japan) (+ on D2 and D4) (fig. [2](#F2){ref-type="fig"}).

Discussion {#sec1_3}
==========

The patient showed allergic sensitivity to diisopropanolamine in the compresses he had used. We believe that sensitization occurred while using the compresses. Diisopropanolamine has a relatively low sensitization potential. It is used in emulsifying agents for cosmetic lotions, neutralizers in cosmetics, and bath preparations \[[@B1]\]. Until now, eight cases of allergic contact dermatitis from diisopropanolamine, including the present case, have been described (table [1](#T1){ref-type="table"}) \[[@B1],[@B2],[@B3],[@B4],[@B5],[@B6]\]. Notably, five of the eight cases were sensitized from using the compress \[[@B1],[@B2],[@B3]\]. The absorption of diisopropanolamine may have been enhanced by the occlusive condition.

We previously reported a case of diffuse erythematic reaction after using compresses \[[@B2]\]. In the previous case, three concomitant sensitizations to diisopropanolamine, felbinac, and crotamiton supposedly caused a diffuse erythematic reaction \[[@B2]\]. In the present case, a single sensitization to diisopropanolamine was associated with a diffuse erythema.

Thus, similar phenomena of allergic contact dermatitis with diffuse erythematous reaction may be caused by allergic sensitivity to a different component or different combinations of ingredients in the topical medicament. Patch testing with full ingredients from the manufacturer is essential for detecting the sensitized allergens in each case.

![Rectangular-shaped erythema on the bilateral lower back and the buttock and a diffuse erythema on the trunk and extremities.](cde0002-0050-f01){#F1}

![Patch testing showed positive reaction to diisopropanolamine on day 4.](cde0002-0050-f02){#F2}

###### 

Cases of allergic contact dermatitis due to diisopropanolamine

  Case                               Age/sex   Clinical feature                                                                            Allergen(s)                                                                                                      Products used by the patient
  ---------------------------------- --------- ------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- ------------------------------
  Present case                       87/M      rectangular-shaped, pruritic exudative erythematous macular lesions with diffuse erythema   diisopropanolamine                                                                                               compress containing felbinac
                                                                                                                                                                                                                                                            
  Umebayashi, 2005 \[1\], 1st case   78/F      pruritic erythematous erythema                                                              diisopropanolamine                                                                                               compress containing felbinac
                                                                                                                                                                                                                                                            
  Umebayashi, 2005 \[1\], 2nd case   76/F      erythema and papules                                                                        diisopropanolamine                                                                                               compress containing felbinac
                                                                                                                                                                                                                                                            
  Oiso et al., 2003 \[2\]            65/M      rectangular-shaped, pruritic exudative erythematous macular lesions with diffuse erythema   diisopropanolamine, felbinac, and crotamiton                                                                     compress containing felbinac
                                                                                                                                                                                                                                                            
  Umebayashi, 2000 \[3\]             45/M      rectangular-shaped, pruritic exudative erythema                                             diisopropanolamine                                                                                               compress containing felbinac
                                                                                                                                                                                                                                                            
  Hosokawa et al., 1993 \[4\]        31/F      pruritic exudative erythema                                                                 ketoprofen and oxybenzone as photoallergens, and diisopropanolamine and polyoxyethyleneoreil eter as allergens   a topical lotion
                                                                                                                                                                                                                                                            
  Fujimoto et al., 1989 \[5\]        60/M      severely pruritic diffuse and edematous erythema                                            diisopropanolamine                                                                                               a topical ointment
                                                                                                                                                                                                                                                            
  Cronin, 1980 \[6\]                 ?/F       ?                                                                                           diisopropanolamine                                                                                               a blushing gel
